Renal Cell Carcinoma with IVC Thrombi; Current Concepts and Future Perspectives
Mohammed Ahmed Abdel-Muneem Nouh1,2, Masashi Inui1 and Yoshiyuki Kakehi1
1Department of Urology, Kagawa University, Faculty of Medicine, Kagawa, Japan. 2Department of Urology, Sohag University, Sohag faculty of Medicine, Sohag, Egypt.
Abstract
The incidence of venous extension to the inferior vena cava (IVC) in renal cell carcinoma (RCC) is markedly increased recently mostly due to the advances in diagnostic modalities. Such vascular invasion implies a heightened biologic behavior and a surgical challenge during the course of treatment. In this study, we reviewed the classification guidelines, recent diagnostic tools and up-to-date therapeutic modalities for RCC with IVC tumor thrombi added to the prognostic significance regarding the pathologic nature of vascular invasion; cephalad extent of thrombi and any associated distant metastasis. Also, we are providing our suggestion regarding the use of angioscopy for removal of IVC thrombi in a relatively bloodless field without aggressive surgical manipulations or shunt techniques for maintenance of hemodynamic stability.
Readers of this also read:
- Pemetrexed, Carboplatin, and Concomitant Radiation followed by Surgery for Locally Advanced Esophageal Cancer: Results of a Planned Interim Toxicity Analysis of North Central Cancer Treatment Group Study N044E
- A Hybrid Lesion of Lung Cancer and Aspergillosis
- Mammoth and Elephant Phylogenetic Relationships: Mammut Americanum, the Missing Outgroup
- The Effect of Docetaxel (Taxotere®) on Human Gastric Cancer Cells Exhibiting Low-Dose Radiation Hypersensitivity
- Functional Activities and Immunohistochemical Cellular Distribution of Glutathione S-Transferases in Normal, Dysplastic, and Squamous Cell Carcinoma Human Oral Tissues